{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:48:45Z","timestamp":1790765325264,"version":"4.1.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00277-020-04138-8","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T12:02:57Z","timestamp":1593000177000},"page":"1701-1707","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7615-0572","authenticated-orcid":false,"given":"Monia","family":"Marchetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,24]]},"reference":[{"key":"4138_CR1","doi-asserted-by":"crossref","first-page":"104357","DOI":"10.1016\/j.jcv.2020.104357","volume":"127","author":"JA Siordia","year":"2020","unstructured":"Siordia JA (2020) Epidemiology and clinical features of COVID-19: a review of current literature. J Clin Virol 127:104357","journal-title":"J Clin Virol"},{"key":"4138_CR2","doi-asserted-by":"crossref","unstructured":"Giannis D, Ziogas IA, Gianni P (2020) Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERSD-CoV and lessons from the past. J Virol 127:104362","DOI":"10.1016\/j.jcv.2020.104362"},{"key":"4138_CR3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.thromres.2020.04.014","volume":"190","author":"R Esher","year":"2020","unstructured":"Esher R, Breakey N, Lammle B (2020) Severe COVID-19 infection associated with endothelial activation. Thromb Res 190:62","journal-title":"Thromb Res"},{"key":"4138_CR4","doi-asserted-by":"publisher","unstructured":"Fattahi F, Zetoune FS, Ward PA (2020) Complement as a major induced of harmful events in infectious sepsis. Shock. https:\/\/doi.org\/10.1097\/SHK.0000000000001531","DOI":"10.1097\/SHK.0000000000001531"},{"key":"4138_CR5","doi-asserted-by":"crossref","unstructured":"Russkamp NF, Ruemmler R, Roewe J, Moore BB, Ward PA, Bosmann M (2015) Experimental design of complement component C5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin. FASEB J 29:3762\u20133772","DOI":"10.1096\/fj.15-271635"},{"key":"4138_CR6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/cei.13166","volume":"194","author":"CD Barrett","year":"2018","unstructured":"Barrett CD, Hsu AT, Ellson CD et al (2018) Blood clotting and traumatic injury with shock mediates complement-dependent neutrophil priming for extracellular ROS, ROS-dependent organ injury and coagulopathy. Clin Exp Immunol 194:103\u2013117","journal-title":"Clin Exp Immunol"},{"key":"4138_CR7","first-page":"86","volume":"7","author":"PA Ward","year":"2016","unstructured":"Ward PA, Fattahi F, Bosmann M (2016) New insights into molecular mechanisms of immune complex-induced injury in lung. Front Immunol 7:86","journal-title":"Front Immunol"},{"key":"4138_CR8","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1096\/fj.201700140R","volume":"31","author":"F Fattahi","year":"2017","unstructured":"Fattahi F, Kalbitz M, Malan EA, Abe E, Jajou L, Huber-Lang MS, Bosmann M, Russell MW, Zetoune FS, Ward PA (2017) Complement-induced activation of MAPKs and Akt during sepsis: role in cardiac dysfunction. FASEB J 31:4129\u20134139","journal-title":"FASEB J"},{"key":"4138_CR9","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/00003246-199405000-00010","volume":"22","author":"TJ Donnelly","year":"1994","unstructured":"Donnelly TJ, Meade P, Jagels M et al (1994) Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury. Crit Care Med 22:768\u2013776","journal-title":"Crit Care Med"},{"key":"4138_CR10","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1086\/429631","volume":"191","author":"WKE Ip","year":"2005","unstructured":"Ip WKE, Chan KH, Law HKW, Tso GHW, Kong EKP, Wong WHS, To YF, Yung RWH, Chow EY, Au KL, Chan EYT, Lim W, Jensenius JC, Turner MW, Peiris JSM, Lau YL (2005) Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis 191:1697\u20131704","journal-title":"J Infect Dis"},{"key":"4138_CR11","doi-asserted-by":"crossref","first-page":"e1007105","DOI":"10.1371\/journal.ppat.1007105","volume":"14","author":"J Wang","year":"2018","unstructured":"Wang J, Sahoo M, Lantier L, Warawa J, Cordero H, Deobald K, Re F (2018) Caspase-1-dependent pyroptosis of lung epithelial cells protects from melioidosis while caspase-1 mediates macrophage pyroptosis and production of IL-18. PLoS Pathog 14:e1007105","journal-title":"PLoS Pathog"},{"key":"4138_CR12","doi-asserted-by":"crossref","first-page":"e9859","DOI":"10.1097\/MD.0000000000009859","volume":"97","author":"YC Wang","year":"2018","unstructured":"Wang YC, Liu QX, Liu T, Xu XE, Gao W, Bai XJ, Li ZF (2018) Caspase-1-dependent pyroptosis of peripheral blood mononuclear cells predicts the development of sepsis in severe trauma patients: a prospective observational study. Medicine (Baltimore) 97:e9859","journal-title":"Medicine (Baltimore)"},{"key":"4138_CR13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12967-020-02305-z","volume":"18","author":"MA Khan","year":"2020","unstructured":"Khan MA, Shamma T, Kazmi S, Altuhami A, Ahmed HA, Assiri AM, Broering DC (2020) Hypoxia-induced complement dysregulation is associated with microvascular impairments in mouse tracheal transplants. J Transl Med 18:147","journal-title":"J Transl Med"},{"key":"4138_CR14","first-page":"e13085","volume":"21","author":"YC Lin","year":"2019","unstructured":"Lin YC, Liao YJ, Lee YH (2019) Staphylococcal phosphatidylinositol-specific phospholipase C potentiates lung injury via complement sensitization. Cell Microbiol 21:e13085","journal-title":"Cell Microbiol"},{"key":"4138_CR15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.molimm.2018.06.006","volume":"102","author":"F Fattahi","year":"2018","unstructured":"Fattahi F, Frydrych LM, Bian G (2018) Role of complement C5a and histones in septic cardiomyopathy. Mol Immunol 102:32\u201341","journal-title":"Mol Immunol"},{"key":"4138_CR16","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.3389\/fimmu.2018.02035","volume":"9","author":"HL Orrrem","year":"2018","unstructured":"Orrrem HL, Nilsson PH, Piscke SE (2018) IL-6 receptor inhibition by tocilizumab attenuated expression of C5a receptor 1 and 2 in non-ST-elevation myocardial infarction. Front Immunol 9:2035","journal-title":"Front Immunol"},{"key":"4138_CR17","doi-asserted-by":"crossref","unstructured":"Wang W, Cai D (2020) Complement components sC5b-9 and CH50 predict prognosis in heart failure patients combined with hypertension. Am J Hypertens 33:53\u201360","DOI":"10.1093\/ajh\/hpz140"},{"key":"4138_CR18","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/CIRCRESAHA.117.312153","volume":"122","author":"X-H Chen","year":"2018","unstructured":"Chen X-H, Ruan C-C, Ge Q, Ma Y, Xu JZ, Zhang ZB, Lin JR, Chen DR, Zhu DL, Gao PJ (2018) Deficiency of complement C3 and C5 receptors prevents angiotensin II-induced hypertension via regulatory T cells. Circ Res 122:970\u2013983","journal-title":"Circ Res"},{"key":"4138_CR19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.humpath.2006.01.015","volume":"37","author":"WF Ng","year":"2006","unstructured":"Ng WF, To KF, Lam WWL et al (2006) The comparative pathology of severe acute respiratory syndrome and avian influenza a subtype H5N1-a review. Hum Pathol 37:381\u2013390","journal-title":"Hum Pathol"},{"key":"4138_CR20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1348-0421.2011.00309.x","volume":"55","author":"R Ohta","year":"2011","unstructured":"Ohta R, Torii Y, Imai M, Kimura H, Okada N, Ito Y (2011) Serum concentrations of complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1 influenza. Microbiol Immunol 55:191\u2013198","journal-title":"Microbiol Immunol"},{"key":"4138_CR21","first-page":"e28","volume":"4","author":"R Wang","year":"2015","unstructured":"Wang R, Xiao H, Guo R, Li Y, Shen B (2015) The role of C5a in acute lung injury induced by highly pathogenic viral infections. Emerg Microbes Infect 4:e28","journal-title":"Emerg Microbes Infect"},{"key":"4138_CR22","doi-asserted-by":"publisher","unstructured":"Gralinski LE, Sheahan TP, Morrison TE, et al. (2018) Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis. mBio. 9. doi:https:\/\/doi.org\/10.1128\/mBio.01753-18","DOI":"10.1128\/mBio.01753-18"},{"key":"4138_CR23","doi-asserted-by":"publisher","unstructured":"Jiang Y, Li J, Teng Y, et al. (2019) Complement receptor C5aR1 inhibition reduces pyroptosis in hDPP4-trangenic mice infected with MERS-CoV. Viruses, 11. doi: https:\/\/doi.org\/10.3390\/v11010039","DOI":"10.3390\/v11010039"},{"key":"4138_CR24","doi-asserted-by":"publisher","unstructured":"Yang M (2020) Cell pyroptosis, a potential pathogenic mechanism of 2019-nCoV infection. SSRN. https:\/\/doi.org\/10.2139\/ssrn.3527420","DOI":"10.2139\/ssrn.3527420"},{"key":"4138_CR25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1373\/clinchem.2005.061689","volume":"52","author":"RTK Pang","year":"2006","unstructured":"Pang RTK, Poon TCW, Chan KCA, Lee NLS, Chiu RWK, Tong YK, Wong RMY, Chim SSC, Ngai SM, Sung JJY, Lo YMD (2006) Serum proteomic fingerprints of adult patients with severe acute respiratory syndrome. Clin Chem 52:421\u2013429","journal-title":"Clin Chem"},{"key":"4138_CR26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1165\/rcmb.2012-0428OC","volume":"49","author":"S Sun","year":"2013","unstructured":"Sun S, Zhao G, Liu C, Wu X, Guo Y, Yu H, Song H, du L, Jiang S, Guo R, Tomlinson S, Zhou Y (2013) Inhibition of complement activation alleviates acute lung injury induced by highly pathogenic avian influenza H5N1 virus infection. Am J Respir Cell Mol Biol 49:221\u2013230","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4138_CR27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjh.15790","volume":"185","author":"G Soci\u00e9","year":"2019","unstructured":"Soci\u00e9 G, Caby-Tosi MP, Marantz JL, Cole A, Bedrosian CL, Gasteyger C, Mujeebuddin A, Hillmen P, Vande Walle J, Haller H (2019) Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical uraemic syndrome: 10-year pharmacovigilance analysis. Br J Haemtol 185:297\u2013310","journal-title":"Br J Haemtol"},{"key":"4138_CR28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.idcr.2017.04.004","volume":"9","author":"P Condom","year":"2017","unstructured":"Condom P, Mansury JM, Decramer S et al (2017) Atypical hemolytic uremic syndrome triggered by varicella infection. IDCases 9:89\u201390","journal-title":"IDCases"},{"key":"4138_CR29","doi-asserted-by":"crossref","unstructured":"Fraga-Rodriguez GM, Brio\u2019-Sanguistin S, Turon-Vinas E, et al. (2017) Eculizumab in a child with atypical haemolytic uraemic syndrome and haemophagocytic lymphohistiocytosis triggered by cytomegalovirus infection. BMJ Case Rep","DOI":"10.1136\/bcr-2016-219065"},{"key":"4138_CR30","first-page":"423","volume":"78","author":"R M\u00e9ndez","year":"2019","unstructured":"M\u00e9ndez R, Men\u00e9ndez R, Amara-Elori I et al (2019) Lymphopenic community-acquired pneumonia is associated with a dysregulated immune response and increased severity and mortality. J Inf Secur 78:423\u2013431","journal-title":"J Inf Secur"},{"key":"4138_CR31","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.1038\/s41598-020-62190-w","volume":"10","author":"T Romacho","year":"2020","unstructured":"Romacho T, Valencia I, Ramos-Gonzales M et al (2020) Visfatin\/eNampt induces endothelial dysfunction in vivo: a role for toll-like receptor 4 and NLRP3 inflammasome. Sci Rep 10:5386","journal-title":"Sci Rep"},{"key":"4138_CR32","doi-asserted-by":"crossref","unstructured":"Dolmatova EV, Wang K, Mandavilli R, et al. (2020) The effects of sepsis on endothelium and clinical implications. Cardiovasc Res (in press)","DOI":"10.1093\/cvr\/cvaa070"},{"key":"4138_CR33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.thromres.2016.11.007","volume":"149","author":"M Levi","year":"2017","unstructured":"Levi M, van der Poll T (2017) Coagulation and sepsis. Thromb Res 149:38\u201344","journal-title":"Thromb Res"},{"key":"4138_CR34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13613-019-0499-6","volume":"9","author":"FCF Schmitt","year":"2019","unstructured":"Schmitt FCF, Manolov V, Morgenstern J, Fleming T, Heitmeier S, Uhle F, al-Saeedi M, Hackert T, Bruckner T, Sch\u00f6chl H, Weigand MA, Hofer S, Brenner T (2019) Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study. Ann Intensive Care 9:19","journal-title":"Ann Intensive Care"},{"key":"4138_CR35","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3389\/fimmu.2020.00352","volume":"11","author":"G Shrivastava","year":"2020","unstructured":"Shrivastava G, Visoso-Carvajal G, Carcia-Cordero J et al (2020) Dengue virus serotype 2 and its non-structural proteins 2A and 2B activate TLRP3 inflammasome. Front Immunol 11:352","journal-title":"Front Immunol"},{"key":"4138_CR36","doi-asserted-by":"crossref","first-page":"675","DOI":"10.33549\/physiolres.934105","volume":"68","author":"FS Babu","year":"2019","unstructured":"Babu FS, LaPorte HM, Nassoiy SP, Majetschak M (2019) Chemokine (C-X-C motif) receptor 4 regulates lung endothelial barrier permeability during resuscitation from hemorrhagic shock. Physiol Res 68:675\u2013679","journal-title":"Physiol Res"},{"key":"4138_CR37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.thromres.2019.07.013","volume":"181","author":"N Gupta","year":"2019","unstructured":"Gupta N, Zhao YY, Evans CE (2019) The stimulation of thrombosis by hypoxia. Thromb Res 181:77\u201383","journal-title":"Thromb Res"},{"key":"4138_CR38","doi-asserted-by":"crossref","first-page":"538","DOI":"10.2353\/ajpath.2007.060469","volume":"170","author":"J Ye","year":"2007","unstructured":"Ye J, Zhang B, Xu J, Chang Q, McNutt MA, Korteweg C, Gong E, Gu J (2007) Molecular pathology in the lungs of severe acute respiratory syndrome patients. Am J Pathol 170:538\u2013545","journal-title":"Am J Pathol"},{"issue":"4","key":"4138_CR39","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18(4):844\u2013847","journal-title":"J Thromb Haemost"},{"key":"4138_CR40","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1440-1843.2007.01102.x","volume":"12","author":"JCK Chan","year":"2007","unstructured":"Chan JCK, Tsui ELH, Wong VCW et al (2007) Prognostication in severe acute respiratory syndrome: a retrospective time-course analysis of 1312 laboratory-confirmed patients in Hong Kong. Respirology 12:531\u2013542","journal-title":"Respirology"},{"key":"4138_CR41","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s12013-014-0050-1","volume":"70","author":"P Zhou","year":"2014","unstructured":"Zhou P, Ma B, Xu S, Zhang S, Tang H, Zhu S, Xiao S, Ben D, Xia Z (2014) Knockdown of Bruton\u2019s kinase tyrosine kinase confers potent protection against sepsis-induced acute lung injury. Cell Biochem Biophys 70:1265\u20131275","journal-title":"Cell Biochem Biophys"},{"key":"4138_CR42","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1111\/jcmm.15130","volume":"24","author":"L Xu","year":"2020","unstructured":"Xu L, Geng T, Zang G, Bo L, Liang Y, Zhou H, Yan J (2020) Exosome derived from CD137-modified endothelial cells regulates the Th17 responses in atherosclerosis. J Cell Mol Med 24:4659\u20134667","journal-title":"J Cell Mol Med"},{"key":"4138_CR43","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/10799893.2020.1738484","volume":"40","author":"K Lu","year":"2020","unstructured":"Lu K, Zhao J, Liu W et al (2020) Macrophage stimulating 1-induced inflammation response promotes aortic aneurysm formation through triggering endothelial cells death and activating NF-kB signaling pathway. J Recept Signal Transduction 40:374\u2013382","journal-title":"J Recept Signal Transduction"},{"key":"4138_CR44","first-page":"101273","volume":"28","author":"X Li","year":"2020","unstructured":"Li X, Fang P, Sun Y et al (2020) Anti-inflammatory cytokines IL-35 and IL-10 block atherogenic lysophosphatidylcholine-induced, mitochondrial ROS-mediated innate immune activation, but spare innate immune memory signature in endothelial cells. Redox Biol 28:101273","journal-title":"Redox Biol"},{"key":"4138_CR45","first-page":"L1097","volume":"318","author":"S Agarwal","year":"2020","unstructured":"Agarwal S, Sharma H, Chen L, Dhillon NK (2020) NADPH oxidase mediated endothelial injury in HIV and opioid induced pulmonary arterial hypertension. Am J Phys Lung Cell Mol Phys 318:L1097\u2013L1108","journal-title":"Am J Phys Lung Cell Mol Phys"},{"key":"4138_CR46","doi-asserted-by":"crossref","first-page":"117571","DOI":"10.1016\/j.lfs.2020.117571","volume":"252","author":"H He","year":"2020","unstructured":"He H, Xiao S, Xu G et al (2020) the NADPH oxidase 4 protects vascular endothelial cells from copper oxide nanoparticles-induced oxidative stress and cell death. Life Sci 252:117571","journal-title":"Life Sci"},{"key":"4138_CR47","doi-asserted-by":"crossref","first-page":"114423","DOI":"10.1016\/j.envpol.2020.114423","volume":"263","author":"Y Cui","year":"2020","unstructured":"Cui Y, Chen G, Yang Z (2020) Mitochondrial superoxide mediates PM2.5-induced cytotoxicity in human pulmonary lymphatic endothelial cells. Environ Pollut 263:114423","journal-title":"Environ Pollut"},{"key":"4138_CR48","doi-asserted-by":"crossref","unstructured":"Connor DE, Gerbelli J, Chew AN (2020) Sirolimus and propranolol inhibit endothelial proliferation while detergent sclerosants induce endothelial activation, microparticle release and apoptosis in vitro. Phlebology 268355520913384","DOI":"10.1177\/0268355520913384"},{"key":"4138_CR49","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fphar.2020.00202","volume":"11","author":"W Su","year":"2020","unstructured":"Su W, Zhao J, Fan TJ (2020) Dose- and time-dependent cytotoxycity of cartelol in corneal endothelial cells and the underlying mechanisms. Front Pharmacol 11:202. https:\/\/doi.org\/10.3389\/fphar.2020.00202","journal-title":"Front Pharmacol"},{"key":"4138_CR50","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.bbrc.2020.02.151","volume":"525","author":"J Song","year":"2020","unstructured":"Song J, Hu B, Qu H et al (2020) Upregulation of angiotensin converting enzyme 2 by shear stress reduced inflammation and proliferation in vascular endothelial cells. Biochem Biophys Res Commun 525:812\u2013818","journal-title":"Biochem Biophys Res Commun"},{"key":"4138_CR51","doi-asserted-by":"publisher","unstructured":"Zhang Y, Zhu H, Layritz F (2020) Recombinant adenosine deaminase ameliorates inflammation, vascular disease and fibrosis in preclinical models of systemic sclerosis. Arthritis Rheum. https:\/\/doi.org\/10.1002\/art.41259","DOI":"10.1002\/art.41259"},{"key":"4138_CR52","doi-asserted-by":"crossref","first-page":"104001","DOI":"10.1016\/j.mvr.2020.104001","volume":"130","author":"BM Kalkan","year":"2020","unstructured":"Kalkan BM, Akol S, Ak D et al (2020) Casin and ADM3100 enhance endothelial cell proliferation, tube formation and sprouting. Microvasc Res 130:104001","journal-title":"Microvasc Res"},{"key":"4138_CR53","doi-asserted-by":"crossref","unstructured":"Geven C, Bergmann A, Kox M, Pickkers P (2018) Vascular effects of adrenomedullin and the anti-adrenomedullin antibody adrecizumab in sepsis. Shock 50:132\u2013140","DOI":"10.1097\/SHK.0000000000001103"},{"key":"4138_CR54","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","volume":"506","author":"G Lippi","year":"2020","unstructured":"Lippi G, Plebani M, Henry BM (2020) Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID \u221219) infections: a meta-analysis. Clin Chem Acta 506:145\u2013148","journal-title":"Clin Chem Acta"},{"issue":"6","key":"4138_CR55","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00277-020-04019-0","volume":"99","author":"P Xu","year":"2020","unstructured":"Xu P, Zhou Q, Xu J (2020) Mechanism of thrombocytopenia in COVID-19 patients. Version 2. Ann Hematol 99(6):1205\u20131208. https:\/\/doi.org\/10.1007\/s00277-020-04019-0","journal-title":"Ann Hematol"},{"key":"4138_CR56","doi-asserted-by":"publisher","unstructured":"Liu X, Zhang R, He G (2020) Hematological findings in coronavirus disease 2019: indications of progression of disease. Ann Hematol. https:\/\/doi.org\/10.1007\/s00277-020-04103-5 Epub ahead of print","DOI":"10.1007\/s00277-020-04103-5"},{"key":"4138_CR57","doi-asserted-by":"crossref","unstructured":"Yin S, Huang M, Li D (2020) Difference of coagulation features between severe pneumonia induced by SARS-SoV2 and non-SARS-CoV2. J Thromb Thrombolysis","DOI":"10.1007\/s11239-020-02105-8"},{"key":"4138_CR58","first-page":"A7353","volume":"199","author":"G Bellingan","year":"2019","unstructured":"Bellingan G, Jacono F, Bannard SJ et al (2019) Primary analysis of a phase 1\/2 study to assess MultiStem\u00ae cell therapy, a regenerative advanced medicinal product (ATMP) in acute respiratory distress syndrome (MUST-ARDS). Am J Respir Crit Care Med 199:A7353","journal-title":"Am J Respir Crit Care Med"},{"key":"4138_CR59","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40635-015-0072-z","volume":"31","author":"T Iba","year":"2015","unstructured":"Iba T, Hashiguci N, Nagaoka I et al (2015) Heparins attenuated histone-mediated cytotoxicity in vitro and improved the survival in a rat model of histone-induced organ dysfunction. Intensive Care Med Exp 31:36","journal-title":"Intensive Care Med Exp"},{"key":"4138_CR60","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jss.2019.01.020","volume":"238","author":"Y Liu","year":"2019","unstructured":"Liu Y, Mu S, Li X, Liang Y, Wang L, Ma X (2019) Unfractionated heparin alleviates sepsis-induced acute lung injury by protecting tight junctions. J Surg Res 238:175\u2013185","journal-title":"J Surg Res"},{"issue":"117","key":"4138_CR61","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1160\/TH16-08-0620","volume":"28","author":"TJ Potterucha","year":"2017","unstructured":"Potterucha TJ, Libby P, Goldhaber SZ (2017) More than an anticoagulant: do heparins have direct anti-inflammatory effects? Thromb Haemost 28(117):437\u2013444","journal-title":"Thromb Haemost"},{"key":"4138_CR62","doi-asserted-by":"crossref","unstructured":"SeuNg H, Wadle C, Hopp T, et al. (2018) P2Y12 is involved in emergency hematopoiesis after myocardial infarction. Eur Heart J 39 suppl 1: 694","DOI":"10.1093\/eurheartj\/ehy563.P3443"},{"key":"4138_CR63","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1096\/fj.201802650RR","volume":"33","author":"R Bartoszewski","year":"2019","unstructured":"Bartoszewski R, Moszy\u0144ska A, Serocki M, Cabaj A, Polten A, Ochocka R, Dell'Italia L, Bartoszewska S, Kr\u00f3liczewski J, D\u0105browski M, Collawn JF (2019) Primary endothelial cell-specific regulation of hypoxia-inducible factor (HIF)-1 and HIF-2 and their target gene expression profiles during hypoxia. FASEB J 33:7929\u20137941","journal-title":"FASEB J"},{"key":"4138_CR64","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1172\/JCI77701","volume":"125","author":"H Gong","year":"2015","unstructured":"Gong H, Rehman J, Tang H, Wary K, Mittal M, Chatturvedi P, Zhao Y, Komorova YA, Vogel SM, Malik AB (2015) HIF2alpha signaling inhibits adherens junctional disruption in acute lung injury. J Clin Invest 125:652\u2013664","journal-title":"J Clin Invest"},{"key":"4138_CR65","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/SHK.0000000000001312","volume":"52","author":"MV Suresh","year":"2019","unstructured":"Suresh MV, Malijepalli S, Zhang B (2019) Hypoxia-inducible factor (HIF)-1alpha promotes inflammation and injury following aspiration-induced lung injury in mice. Shock 52:612\u2013621","journal-title":"Shock"},{"key":"4138_CR66","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.4161\/cbt.6.11.4854","volume":"6","author":"Y Kimura","year":"2007","unstructured":"Kimura Y, Inoue K, Abe M, Nearman J, Baranowska-Kortylewicz J (2007) PDGFR\u03b2 and HIF-1\u03b1 inhibition with imatinib and radioimmunotherapy of experimental prostate cancer. Cancer Biol Ther 6:1763\u20131772","journal-title":"Cancer Biol Ther"},{"key":"4138_CR67","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1160\/th13-12-1031","volume":"112","author":"C Veith","year":"2014","unstructured":"Veith C, Zakrzewicz D, Dahal BK (2014) Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorilation in pulmonary hypertension is reversed by HIF-1alpha depletion or imatinib treatment. Thromb Haemost 112:1288\u20131303","journal-title":"Thromb Haemost"},{"key":"4138_CR68","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1183\/13993003.01188-2018","volume":"54","author":"Y Takei","year":"2019","unstructured":"Takei Y, Yamada M, Saito K et al (2019) Increase in circulating ACE-positive endothelial microparticles during acute lung injury. Eur Respir J 54:4","journal-title":"Eur Respir J"},{"key":"4138_CR69","first-page":"231","volume":"2","author":"MD Moussa","year":"2014","unstructured":"Moussa MD, Santonocito C, Fagnoul D et al (2014) Evaluation of endothelial damage in sepsis-related ARDS using circulating endothelial cells. Intensive Care Med 2:231\u2013238","journal-title":"Intensive Care Med"},{"key":"4138_CR70","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1097\/01.CCM.0000269034.86817.59","volume":"7","author":"N Rafat","year":"2007","unstructured":"Rafat N, Nanusch C, Brikkoetter PT et al (2007) Increased circulating endothelial progenitor cells in septic patients: correlation with survival. Crit Care Med 7:1677\u20131684","journal-title":"Crit Care Med"},{"key":"4138_CR71","first-page":"e33859","volume":"3","author":"Y Qi","year":"2017","unstructured":"Qi Y, Qian L, Sun B et al (2017) Inhaled NO contributes to lung repair in piglets with acute respiratory distress syndrome via increasing circulating endothelial progenitor cells. PLoS One 3:e33859","journal-title":"PLoS One"},{"key":"4138_CR72","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.intimp.2011.05.019","volume":"11","author":"X Gao","year":"2011","unstructured":"Gao X, Chen W, Liang Z, Chen L (2011) Autotransplantation of circulating endothelial progenitor cells protects against lipopolysaccharide-induced acute lung injury in rabbit. Int Immunopharmacol 11:1584\u20131590","journal-title":"Int Immunopharmacol"},{"key":"4138_CR73","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1517\/14728222.2013.773975","volume":"17","author":"X Liu","year":"2013","unstructured":"Liu X, Tan W, Liu Y, Lin G, Xie C (2013) The role of the beta2 adrenergic receptor on endothelial progenitor cells dysfunction of proliferation and migration in chronic obstructive pulmonary disease patients. Expert Opin Ther Targets 17:485\u2013500","journal-title":"Expert Opin Ther Targets"},{"key":"4138_CR74","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1164\/ajrccm\/139.3.682","volume":"139","author":"R Hallgren","year":"1989","unstructured":"Hallgren R, Samuelsson T, Laurent TC et al (1989) Accumulation of hyaluronan (hyaluronic acid) in the lung in adult respiratory distress syndrome. Am Rev Respir Dis 139:682\u2013687","journal-title":"Am Rev Respir Dis"},{"key":"4138_CR75","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.matbio.2018.06.006","volume":"80","author":"TJ Bell","year":"2018","unstructured":"Bell TJ, Borgan DJ, Salek-Ardakani S et al (2018) Defective lung function following influenza virus is due to prolonged, reversible hyaluronan synthesis. Matrix Biol 80:14\u201328","journal-title":"Matrix Biol"},{"key":"4138_CR76","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/bph.13947","volume":"174","author":"SD Collum","year":"2017","unstructured":"Collum SD, Chen NY, Hernandez AM et al (2017) Inhibition of hyaluronan synthesis attenuates pulmonary hypertension associated with lung fibrosis. Br J Pharmacol 174:284\u2013301","journal-title":"Br J Pharmacol"},{"key":"4138_CR77","first-page":"L259","volume":"308","author":"E Letsiou","year":"2015","unstructured":"Letsiou E, Rizzo AN, Sammani S, Naureckas P, Jacobson JR, Garcia JGN, Dudek SM (2015) Differential and opposing effects of imatinib on LPS- and ventilator-induced lung injury. Am J Phys Lung Cell Mol Phys 308:L259\u2013L269","journal-title":"Am J Phys Lung Cell Mol Phys"},{"key":"4138_CR78","doi-asserted-by":"crossref","unstructured":"Aman J, van Bezu J, Damanafshan A, Huveneers S, Eringa EC, Vogel SM, Groeneveld ABJ, Vonk Noordegraaf A, van Hinsbergh VWM, van Nieuw Amerongen GP (2012) Effective treatment of edema and endothelial barrier dysfunction with imatinib. Circulation 126:2728\u20132738","DOI":"10.1161\/CIRCULATIONAHA.112.134304"},{"key":"4138_CR79","first-page":"L1294","volume":"309","author":"R An","year":"2015","unstructured":"An R, Ammani S, Esquinca AE et al (2015) Imatinib attenuates inflammation and vascular leak in a clinically relevant two-hit model of acute lung injury. Am J Phys Lung Cell Mol Phys 309:L1294\u2013L1304","journal-title":"Am J Phys Lung Cell Mol Phys"},{"key":"4138_CR80","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.bja.2017.11.095","volume":"120","author":"NJ Koning","year":"2018","unstructured":"Koning NJ, de Lange F, van Meurs M, Jongman RM, Ahmed Y, Schwarte LA, van Nieuw Amerongen GP, Vonk ABA, Niessen HW, Baufreton C, Boer C (2018) Reduction of vascular leakage by imatinib is associated with preserved microcirculatory perfusion and reduced renal injury markers in a rat model of cardiopulmonary bypass. Br J Anaesth 120:1165\u20131175","journal-title":"Br J Anaesth"},{"key":"4138_CR81","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1620\/tjem.247.69","volume":"247","author":"H Sato","year":"2019","unstructured":"Sato H, Sugimura K, Miura M, Konno R, Kozu K, Yaoita N, Shimizu T, Yamamoto S, Aoki T, Tatebe S, Satoh K, Shimokawa H (2019) Beneficial effects of imatinib in a patient with suspected pulmonary veno-occlusive disease. Tohoku J Exp Med 247:69\u201373","journal-title":"Tohoku J Exp Med"},{"key":"4138_CR82","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1183\/09031936.00054407","volume":"32","author":"MJ Overbeek","year":"2008","unstructured":"Overbeek MJ, van Nieuw Amerongen GP, Boonstra A, Smit EF, Vonk-Noordegraaf A (2008) Possible role of imatinib in clinical pulmonary veno-occlusive disease. Eur Respir J 32:232\u2013235","journal-title":"Eur Respir J"},{"key":"4138_CR83","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1186\/s12885-016-2833-9","volume":"16","author":"E Feniocchio","year":"2016","unstructured":"Feniocchio E, Depetris I, Campanella D et al (2016) Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case report. BMC Cancer 16:793","journal-title":"BMC Cancer"},{"key":"4138_CR84","doi-asserted-by":"crossref","first-page":"e691","DOI":"10.1200\/JCO.2011.35.6733","volume":"29","author":"F Carnevale-Schianca","year":"2010","unstructured":"Carnevale-Schianca F (2010) S. Gallo, D. Rota-Scalabrini, D. Complete resolution of life-threatening bleomycin-induced pneumonitis after treatment with imatinib mesylate in a patient with Hodgkin\u2019s lymphoma: hope for severe chemotherapy-induced toxicity? J Clin Oncol 29:e691\u2013e693","journal-title":"J Clin Oncol"},{"key":"4138_CR85","doi-asserted-by":"crossref","first-page":"e1004770","DOI":"10.1371\/journal.ppat.1004770","volume":"11","author":"RJ Napier","year":"2015","unstructured":"Napier RJ, Norris RA, Swimm A (2015) Low dose of imatinib induce myelopoiesis and enhance host anti-microbial immunity. PLoS Pathog 11:e1004770","journal-title":"PLoS Pathog"},{"key":"4138_CR86","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood-2019-130275","volume":"134","author":"CR Giver","year":"2019","unstructured":"Giver CR, Shaw PA, Fletcher H et al (2019) IMPACT-TB: a phase II trial assessing the capacity of low dose imatinib to induce myelopoiesis and enhance host anti-microbial immunity against tuberculosis. Imatinib Mesylate per Oral As a Clinical Therapeutic for TB. Blood 134:1050","journal-title":"Blood"},{"key":"4138_CR87","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1128\/AAC.03036-14","volume":"58","author":"J Dyall","year":"2014","unstructured":"Dyall J, Coleman CM, Hart BJ, Venkataraman T, Holbrook MR, Kindrachuk J, Johnson RF, Olinger GG Jr, Jahrling PB, Laidlaw M, Johansen LM, Lear-Rooney CM, Glass PJ, Hensley LE, Frieman MB (2014) Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother 58:4885\u20134893","journal-title":"Antimicrob Agents Chemother"},{"key":"4138_CR88","doi-asserted-by":"crossref","first-page":"8924","DOI":"10.1128\/JVI.01429-16","volume":"90","author":"CM Coleman","year":"2016","unstructured":"Coleman CM, Sisk JM, Mingo RM, Nelson EA, White JM, Frieman MB (2016) Abelson kinase inhibitors are potent inhibitors of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus fusion. J Virol 90:8924\u20138933","journal-title":"J Virol"},{"key":"4138_CR89","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1099\/jgv.0.001047","volume":"99","author":"JM Sisk","year":"2018","unstructured":"Sisk JM, Frieman MB, Machmer CE (2018) Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors. J Gen Virol 99:619\u2013630","journal-title":"J Gen Virol"},{"key":"4138_CR90","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.00102-14","volume":"28","author":"JF Chan","year":"2015","unstructured":"Chan JF, Lau SK, To KK et al (2015) Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev 28:465\u2013522","journal-title":"Clin Microbiol Rev"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04138-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-020-04138-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04138-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:41:33Z","timestamp":1624495293000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-020-04138-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,24]]},"references-count":90,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["4138"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-04138-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,24]]},"assertion":[{"value":"1 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MM has received speaker honorarium from Novartis and consultant fees from Gilead.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}